David Jonathan Powell, Chief Scientific Officer at Summit Therapeutics Inc. (SMMT), sold 42,501 shares at $4.32 ($183K) on 2020-11-25, disclosed to the SEC on 2020-11-25.
Open-market sale of $183k SMMT by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.40 | 6,987 | $31K | 16.8% |
| 2 | $4.21 | 11,374 | $48K | 26.2% |
| 3 | $4.32 | 12,070 | $52K | 28.5% |
| 4 | $4.32 | 12,070 | $52K | 28.5% |
| Total | $4.30 avg | 42,501 | $183K | 100% |